Answers are grounded in this paper and cite their sources.
European guidelines question the requirement for intestinal biopsies to diagnose celiac disease in children. To determine the specificity of serological diagnosis of celiac disease (CD) using antitissue transglutaminase antibody (aTTG) levels in a general pediatric referral population. Children referred from 2005 to 2008 with a positive aTTG test were included, regardless of symptoms. Diagnostic endoscopy was performed and a minimum of six biopsies were obtained. Histological samples were reviewed in a blinded manner, and specificities and sensitivities of aTTG threshold levels for a diagnostic Marsh score ≥3 were determined. A total of 115 eligible patients were identified, 73% of whom had a Marsh score ≥3. The specificity of an aTTG level of ≥100 U/mL was 97% (95% CI 93.5% to 100%); an aTTG level ≥200 U/mL was 100% (95% CI 89% to 100%) specific. Further research is required before considering a change in diagnostic standards in Canada. In this region, the threshold aTTG level to provide diagnostic specificity of 100% is significantly greater than the threshold aTTG level being proposed for diagnosis in Europe.
No takes yet. Share an insight, caveat, or question.
Saginur et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: